ASHLEY CHANDLER: Open Payments
NPI 1467013078 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 32 payments from 14 companies in 2025. Trend: 2023 $641 · 2024 $182 · 2025 $896
Food & beverage: $796Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $177 |
| Galderma Laboratories, L.P. | 6 | $147 |
| Organon LLC | 2 | $117 |
| Arcutis Biotherapeutics, Inc. | 2 | $112 |
| UCB, Inc. | 2 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| GENZYME CORPORATION | 1 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| LEO Pharma Inc. | 1 | $31 |
| PFIZER INC. | 1 | $26 |
Products named: TREMFYA, NEMLUVIO, Zoryve, VTAMA, Bimzelx, DUPIXENT, ILUMYA, COSENTYX.
Industry payments across GA — which companies pay providers there.
